SUMMARY The EEG and clinical records were reviewed of 85 subjects who had been treated for complex partial seizures with carbamazepine alone or with a combination of carbamazepine and sodium valproate. There was a correlation between the site of the EEG abnormality and the therapeutic response to anticonvulsant therapy. Subjects who had a left sided temporal lobe EEG abnormality responded better to carbamazepine alone, while those who had an abnormality on the right responded to a combination of carbamazepine and sodium valproate.
It has been well documented that the site of temporal lesions plays a vital role in the symptomatology of complex partial seizures. ' In an earlier study we reported that autonomic and psychic auras are more frequently associated with right sided temporal lobe lesions.5 A similar observation has also emerged from studies of other workers.6-8 Recently there have been a few reports where the site of temporal lobe lesions was correlated with certain neuropsychiatric disorders.29-'3 Despite this, very little information is available about the appropriate choice of anticonvulsant therapy, although several reports have indicated that carbamazepine is the drug of choice in partial epilepsies '4-'7 and valproic acid in generalised seizures. [18] [19] [20] [21] [22] However, other than the work of Shakir et al, 13 (table 2) , In subjects who were seizure-free on carbamazepine of whom 24 had a left temporal EEG abnormality, as the sole drug of treatment, the serum carseven had a right sided abnormality and nine had a bamazepine levels were not significantly different bilateral abnormality.
between those who responded to treatment and In 45 patients (table 3) complete control of seiz-those who did not (t = 1-326, NS). In the subse- quent group of patients who failed to respond to carbamazepine but became seizure-free on adding sodium valproate, the serum carbamazepine levels were, not surprisingly, different in patients who did not respond from those who did (t = 1-266, NS). However, the serum levels of valproic acid were significantly lower in patients who did respond compared to patients who did not (t = 3 371 p < 0.001).
Discussion
Although there are certain drawbacks in our study, such as lack of a control sample and the absence of a comparative group of patients with sodium valproate as a sole drug of treatment, our results indicate that patients with an active epileptogenic focus in the left temporal lobe respond better to carbamazepine. Patients with an abnormality on the right respond better to a combination of carbamazepine and sodium valproate. This variation in the response to drug treatment and site of the temporal lobe lesion is difficult to explain. Table 2 shows that more than 60% of the subjects with a left temporal abnormality responded to carbamazepine compared to only 12% in whom the abnormality was on the right. It is also interesting to note that when sodium valproate was added in uncontrolled subjects (N = 45), only 22 responded and the majority of them had an abnormality in the right temporal lobe (Xe-12.9; p < 0.001). patients with partial epilepsy and found both drugs similar in efficacy, sodium valproate being slightly more effective. Bruni and Albright32 found that 50% of patients with complex partial seizures had a significant reduction in the number of seizures when treated with sodium valproate. However, the longterm benefit was very limited as half of those who responded showed an increase in seizure frequency after the 3 month period. These workers also concluded that the long-term efficacy of sodium valproate depended to a certain extent upon the pre-drug seizure frequency. We were unable to observe any significant relationship between the serum carbamazepine levels of controlled and uncontrolled patients, while they were on carbamazepine alone or while being treated with a combination of carbamazepine and sodium valproate. However, our results clearly indicate significantly higher serum valproic acid levels in patients who did not respond to a combination of carbamazepine and sodium valproate, than those who became seizure free on this combination (table  4) . The possible explanation for the higher serum levels of valproic acid in uncontrolled subjects is that there is a tendency for the clinician to increase the dose far above the maximum recommended dosages, in the hope that this will control the seizures. This explanation, to a certain extent, is true for our own uncontrolled patients, as the mean daily dose of sodium valproate was significantly higher in those not controlled, compared with those controlled with carbamazepine and sodium valproate (p < 0.001).
Goggin et aP3 also noticed a similar tendency for higher valproic acid levels in their sample of poorly controlled patients with different types of seizures, treated with sodium valproate alone.
From the literature on the drug treatment of complex partial seizures, it can be seen that the results differ from subject to subject and according to the type of sample in the drug trial, and the nature of the seizure, and duration of epilepsy.
The results of this study indicate that both carbamazepine and sodium valproate are effective in the treatment of complex partial seizures, but the outcome of the drug treatment in our sample depends, to a certain extent, upon the site of the active epileptogenic focus, for which we have no explanation.
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